Literature DB >> 23293460

A study on the toxic effects of Doxorubicin on the histology of certain organs.

P Shivakumar1, M Usha Rani, A Gopala Reddy, Y Anjaneyulu.   

Abstract

In the present study, effect of doxorubicin at 2 mg/kg b.wt. (i/p), alone, once in a wk for 4 wks and in combination with vitamin E at 250 and 500 mg/kg b.wt., orally, daily for 4 wks was evaluated on histological alterations, if any, on heart, liver, kidney, and testes of rats. Doxorubicin alone treated group showed marked congestion and degenerative changes in heart, kidney, liver, and testis. Treatment with vitamin E showed marked improvement in all the degenerative changes, though more protection was observed with the dose of 500 mg/kg.

Entities:  

Keywords:  Doxorubicin; histopathology; vitamin-E

Year:  2012        PMID: 23293460      PMCID: PMC3532767          DOI: 10.4103/0971-6580.103656

Source DB:  PubMed          Journal:  Toxicol Int        ISSN: 0971-6580


  7 in total

1.  Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin.

Authors:  Yusuf Kalender; Mustafa Yel; Suna Kalender
Journal:  Toxicology       Date:  2005-01-08       Impact factor: 4.221

Review 2.  Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review.

Authors:  E L De Beer; A E Bottone; E E Voest
Journal:  Eur J Pharmacol       Date:  2001-03-09       Impact factor: 4.432

3.  Pattern of childhood cancer mortality in Mexico.

Authors:  F I Abdullaev; R Rivera-Luna; V Roitenburd-Belacortu; J Espinosa-Aguirre
Journal:  Arch Med Res       Date:  2000 Sep-Oct       Impact factor: 2.235

4.  Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius.

Authors:  F Arcamone; G Cassinelli; G Fantini; A Grein; P Orezzi; C Pol; C Spalla
Journal:  Biotechnol Bioeng       Date:  1969-11       Impact factor: 4.530

5.  Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events.

Authors:  T Bertani; A Poggi; R Pozzoni; F Delaini; G Sacchi; Y Thoua; G Mecca; G Remuzzi; M B Donati
Journal:  Lab Invest       Date:  1982-01       Impact factor: 5.662

Review 6.  Vitamin E, antioxidant and nothing more.

Authors:  Maret G Traber; Jeffrey Atkinson
Journal:  Free Radic Biol Med       Date:  2007-03-31       Impact factor: 7.376

Review 7.  Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes.

Authors:  Luca Gianni; Emanuela Salvatorelli; Giorgio Minotti
Journal:  Cardiovasc Toxicol       Date:  2007       Impact factor: 3.231

  7 in total
  20 in total

1.  Polymeric Nanoparticles Controlled by On-Chip Self-Assembly Enhance Cancer Treatment Effectiveness.

Authors:  Sungjin Jung; Junseok Lee; Junha Lim; Jeeyeon Suh; Taeyoung Kim; Jungho Ahn; Won Jong Kim; YongTae Kim
Journal:  Adv Healthc Mater       Date:  2020-10-18       Impact factor: 9.933

Review 2.  Doxorubicin-Induced Cardiomyopathy in Children.

Authors:  Trevi R Mancilla; Brian Iskra; Gregory J Aune
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

3.  Protective effects of zinc oxide nanoparticles against doxorubicin induced testicular toxicity and DNA damage in male rats.

Authors:  Zeynab Khamis El-Maddawy; Walaa Slouma Hamouda Abd El Naby
Journal:  Toxicol Res (Camb)       Date:  2019-06-15       Impact factor: 3.524

Review 4.  The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update.

Authors:  Zahra Torki; Davood Ghavi; Solmaz Hashemi; Yazdan Rahmati; Dara Rahmanpour; Majid Pornour; Mohammad Reza Alivand
Journal:  Cancer Chemother Pharmacol       Date:  2021-09-12       Impact factor: 3.333

5.  Targeting lysophosphatidic acid receptor with Ki16425 impedes T cell lymphoma progression through apoptosis induction, glycolysis inhibition, and activation of antitumor immune response.

Authors:  Vishal Kumar Gupta; Ajay Kumar
Journal:  Apoptosis       Date:  2022-04-02       Impact factor: 4.677

6.  Comparative Therapeutic Potential of Cardioactive Glycosides in Doxorubicin Model of Heart Failure.

Authors:  Raquel da Silva Ferreira; Paula Bretas Ullmann Fernandes; Jéssica Pereira Oliveira da Cruz; Françoise Louanne Araújo Silva; Marthin Raboch Lempek; Gioavanni Naves Canta; Júlio César Cambraia Veado; Matheus Matioli Mantovani; Ana Flávia Machado Botelho; Marília Martins Melo
Journal:  Cardiovasc Toxicol       Date:  2021-10-16       Impact factor: 3.231

7.  Aptamer-armed nanostructures improve the chemotherapy outcome of triple-negative breast cancer.

Authors:  Quanyuan Wan; Zihua Zeng; Jianjun Qi; Zhenghu Chen; Xiaohui Liu; Youli Zu
Journal:  Mol Ther       Date:  2022-02-08       Impact factor: 12.910

8.  Preclinical Studies Evaluating Subacute Toxicity and Therapeutic Efficacy of LQB-118 in Experimental Visceral Leishmaniasis.

Authors:  Edézio Ferreira Cunha-Júnior; Thiago Martino Martins; Marilene Marcuzzo Canto-Cavalheiro; Paulo Roberto Marques; Elyzabeth Avvad Portari; Marsen Garcia Pinto Coelho; Chaquip Daher Netto; Paulo Roberto Ribeiro Costa; Katia Costa de Carvalho Sabino; Eduardo Caio Torres-Santos
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

9.  Chemopreventive Role of Euphorbia neriifolia (Linn) and its Isolated Flavonoid Against N-Nitrosodiethylamine-induced Renal Histopathological Damage in Male Mice.

Authors:  Veena Sharma; Pracheta Janmeda
Journal:  Toxicol Int       Date:  2013-01

10.  Sertoli Cells Loaded with Doxorubicin in Lipid Micelles Reduced Tumor Burden and Dox-Induced Toxicity.

Authors:  Mahasweta Das; Mark Howell; Elspeth A Foran; Rohit Iyre; Shyam S Mohapatra; Subhra Mohapatra
Journal:  Cell Transplant       Date:  2017-10       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.